Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Prospective, Multi-centre, Randomised, Double-blind Comparison of Intravenous Dexmedetomidine With Midazolam for Continuous Sedation of Ventilated Patients in Intensive Care Unit
Brief Summary: Patients in ICU who need help with their breathing are put onto a machine called a ventilator and are also given a medicine, called a sedative, which helps them to sleep and makes them more comfortable. Midazolam is a sedative that is routinely used for these purposes.

For most patients the aim of sedation is to make them sleepy but still able to respond to nursing staff (light sedation)

Dexmedetomidine is a new sedative for use in intensive care and in this clinical study, dexmedetomidine is compared to midazolam. It is thought that dexmedetomidine might be slightly better at allowing patients to be sleepy but still respond to people around them. It also does not appear to affect patient's breathing. the purpose of this study is to test whether dexmedetomidine really does have these advantages compared to midazolam.

in this study we hope to show that: dexmedetomidine is at least as good as midazolam in helping patients to sleep better and making them more comfortable, and that they are able to co-operate better with the staff treating them, and that patients treated with dexmedetomidine require a shorter time on the ventilator than those treated with midazolam.


Options:
A: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Dexmedetomidine | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Midazolam | Intervention Type: DRUG; Name: Dexmedetomidine; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Midazolam; Assigned to Arm(s): 2
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Dexmedetomidine | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Propofol | Intervention Type: DRUG; Name: Dexmedetomidine; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Propofol; Assigned to Arm(s): 2
C: Arm Label: Dexmedetomidine 0.05 mcg/kg; Type: EXPERIMENTAL; Interventions: Drug: Midazolam, Drug: Fentanyl/Morphine, Drug: Dexmedetomidine | Arm Label: Dexmedetomidine 0.1 mcg/kg; Type: EXPERIMENTAL; Interventions: Drug: Midazolam, Drug: Fentanyl/Morphine, Drug: Dexmedetomidine | Arm Label: Dexmedetomidine 0.2 mcg/kg; Type: EXPERIMENTAL; Interventions: Drug: Midazolam, Drug: Fentanyl/Morphine, Drug: Dexmedetomidine | Intervention Type: DRUG; Name: Midazolam; Assigned to Arm(s): Dexmedetomidine 0.05 mcg/kg, Dexmedetomidine 0.1 mcg/kg, Dexmedetomidine 0.2 mcg/kg | Intervention Type: DRUG; Name: Fentanyl/Morphine; Assigned to Arm(s): Dexmedetomidine 0.05 mcg/kg, Dexmedetomidine 0.1 mcg/kg, Dexmedetomidine 0.2 mcg/kg | Intervention Type: DRUG; Name: Dexmedetomidine; Assigned to Arm(s): Dexmedetomidine 0.05 mcg/kg, Dexmedetomidine 0.1 mcg/kg, Dexmedetomidine 0.2 mcg/kg
D: Arm Label: Dexmedetomidine; Type: EXPERIMENTAL; Interventions: Drug: Dexmedetomidine HCL Injection | Arm Label: Midazolam; Type: ACTIVE_COMPARATOR; Interventions: Drug: Midazolam Injection | Intervention Type: DRUG; Name: Dexmedetomidine HCL Injection; Assigned to Arm(s): Dexmedetomidine | Intervention Type: DRUG; Name: Midazolam Injection; Assigned to Arm(s): Midazolam

Answer: A